Better Buy: Gilead Sciences vs. Pfizer

Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE) are each in a state of transition. The top executives at Gilead are totally different than they were just one year ago. Pfizer is in the midst of slimming down and narrowing its focus.

Both drugmakers have faced significant headwinds in the last couple of years. However, both also have reasons to be optimistic about the future. Which stock is the better pick now for long-term investors? Here's how Gilead and Pfizer stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com